2 Structure and Physiology of Glucagon-Like Peptide-1 (GLP-1) The incretin hormone GLP-1 is derived from the processing of proglucagon that occurs in ileal L cells and the nucleus tractus solitarius (NTS) [11]
earlier this month following FDA approval of the drug in September a rare case of a US launch ahead of Europe
This can be particularly advantageous for individuals who may feel stigmatized or overwhelmed by traditional in-person consultations
Results: 13% reduction in MACE , 22% reduction in CV death (Marso et al., 2016)
For similar effects, a study on pea protein hydrolysates showed delayed emptying, reduced ghrelin, and increased satiety (note: while a 2025 study by Katrin Khnke wasn't directly cited, related research supports this finding)
[15] GLP-1 medications facilitate weight loss primarily through reducing appetite and caloric intake and slowing gastric emptying to prolong satiety